mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study.
mRNA COVID-19 vaccine-associated myopericarditis
outcomes
survey
variability
Journal
The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
received:
29
09
2021
revised:
21
11
2021
accepted:
16
12
2021
pubmed:
25
12
2021
medline:
2
4
2022
entrez:
24
12
2021
Statut:
ppublish
Résumé
In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions.
Identifiants
pubmed: 34952008
pii: S0022-3476(21)01231-2
doi: 10.1016/j.jpeds.2021.12.025
pmc: PMC8691954
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
RNA, Messenger
0
Types de publication
Case Reports
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
208-213.e3Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Références
Acad Pediatr. 2016 Sep-Oct;16(7):700-2
pubmed: 27287272
Epilepsia Open. 2020 Aug 11;5(3):461-474
pubmed: 32913954
JAMA. 2021 Sep 14;326(10):902
pubmed: 34519795
J Pediatric Infect Dis Soc. 2021 Nov 11;10(10):962-966
pubmed: 34319393
Pediatrics. 2021 Nov;148(5):
pubmed: 34389692
JAMA Cardiol. 2021 Dec 1;6(12):1446-1450
pubmed: 34374740
J Pediatr. 2021 Nov;238:317-320
pubmed: 34228985
Pediatr Infect Dis J. 2021 Oct 1;40(10):e360-e363
pubmed: 34077949
MMWR Morb Mortal Wkly Rep. 2021 Jul 09;70(27):977-982
pubmed: 34237049
J Pediatr. 2021 Nov;238:26-32.e1
pubmed: 34339728
Am J Cardiol. 2014 Feb 1;113(3):535-40
pubmed: 24332245
Pediatrics. 2021 Sep;148(3):
pubmed: 34088762
Circulation. 2021 Aug 10;144(6):471-484
pubmed: 34281357